Literature DB >> 20059750

The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.

Ali Acar1, Sabri Kemahli, Husnu Altunay, Erdogan Kosan, Oral Oncul, Levent Gorenek, Saban Cavuslu.   

Abstract

The purpose of this study was to investigate the intra-assay correlations amongst initial reactive and repeat screening results used in enzyme immunoassays (EIAs) for hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV in blood donors. This study evaluated the value of using the power of the signal to cut-off (S/CO) ratio index for confirming anti-HCV/HIV reactive screening results, thereby touching upon the utility of S/CO indices in determining whether further confirmatory testing was necessary. Screening test results of the 72,695 blood donors were evaluated over a 1-year period. Correlation analysis among each initial test and retests was done by Pearson r test. Appropriate S/CO values to determine the need of the confirmation testing was investigated by ROC analyses. EIA intra-assay correlations were of statistical significance and were determined as follows: 0.948 for anti-HCV, 0.827 for anti-HIV and 0.948 for HBsAg. The threshold S/CO ratio values which predicted more than 95% of the confirmation test result were 3.8 for HCV and 5.6 for HIV. We were able to demonstrate a strong level of intra-assay correlation amongst EIAs, thereby eliminating the need for repetition of the screening test. Hence, we suggest that repeat screening should only be limited to HBV and HIV tests with low EIA S/CO ratios. Thus, using the power of the S/CO ratio in determining the need for HCV confirmation testing can be a cost-effective measure, especially if the S/CO value is >or=3.8.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20059750     DOI: 10.1111/j.1365-3148.2009.00987.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  12 in total

1.  Different Re-centrifugation Conditions for Infectious Disease Screening Using the Abbott I2000.

Authors:  Dong-Jiang Xu; Ke-di Wang; Jun Wu
Journal:  Curr Med Sci       Date:  2020-03-13

2.  Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer.

Authors:  Jiayi Hou; Jianping Ren; Ling Song; Fen Zhao; Peijun Liang
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

3.  Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list.

Authors:  Metin Basaranoglu; Sonia M Najjar; Ali Ebag Demirbag; Hakan Senturk
Journal:  World J Hepatol       Date:  2016-03-08

4.  Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.

Authors:  Claude Tayou Tagny; Dora Mbanya; Edward L Murphy; Jean-Jacques Lefrère; Syria Laperche
Journal:  J Virol Methods       Date:  2014-01-30       Impact factor: 2.014

5.  Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.

Authors:  Dušan Vučetić; Gorica Kecman; Vesna Ilić; Bela Balint
Journal:  Blood Transfus       Date:  2015-05-22       Impact factor: 3.443

6.  A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.

Authors:  Tomas Ostergaard Jensen; Peter Robertson; Ross Whybin; Ian Chambers; Monica Lahra; William Rawlinson; Jeffrey John Post
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

7.  Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy.

Authors:  Linda Sommese; Carmela Iannone; Francesco Cacciatore; Gustavo De Iorio; Claudio Napoli
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

8.  HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection.

Authors:  Lisa Li; David Puddicombe; Sylvie Champagne; Agatha Jassem; Mel Krajden; Linda Merrick; Christopher Lowe; Michael Payne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-03       Impact factor: 3.267

9.  Usefulness of a fourth generation ELISA assay for the reliable identification of HCV infection in HIV-positive adults from Gabon (Central Africa).

Authors:  François Rouet; Luc Deleplancque; Berthold Bivigou Mboumba; Jeanne Sica; Augustin Mouinga-Ondémé; Florian Liégeois; Alain Goudeau; Frédéric Dubois; Catherine Gaudy-Graffin
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

Review 10.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.